SI2297148T1 - Novi derivati premoščen piperazinil alkanona in njihova uporaba kot p inhibitorji - Google Patents

Novi derivati premoščen piperazinil alkanona in njihova uporaba kot p inhibitorji

Info

Publication number: SI2297148T1
Authority: SI; Slovenia
Prior art keywords: alcanone; inhibitors; novel derivatives; bridged piperazinyl; piperazinyl
Prior art date: 2008-06-13

Application number

SI200930220T

Other languages

English (en)

Inventor

Marco Baroni

Francoise Bono

Sandrine Delbary-Gossart

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-13

Filing date

2009-06-12

Publication date

2012-05-31

2009-06-12 Application filed by Sanofi Sa filed Critical Sanofi Sa

2012-05-31 Publication of SI2297148T1 publication Critical patent/SI2297148T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Cardiology (AREA)
Dermatology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)

SI200930220T 2008-06-13 2009-06-12 Novi derivati premoščen piperazinil alkanona in njihova uporaba kot p inhibitorji SI2297148T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0803299A FR2932482B1 (fr)	2008-06-13	2008-06-13	Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75
EP09761939A EP2297148B8 (fr)	2008-06-13	2009-06-12	NOUVEAUX DERIVES DE (PIPERAZINYL PONTE)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75
PCT/FR2009/051118 WO2009150388A1 (fr)	2008-06-13	2009-06-12	NOUVEAUX DERIVES DE (PIPERAZINYL PONTE)-1-ALCANONE ET LEUR UTILISATION COMME INHIBITEURS DE p75

Publications (1)

Publication Number	Publication Date
SI2297148T1 true SI2297148T1 (sl)	2012-05-31

Family

ID=40305395

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200930220T SI2297148T1 (sl)	2008-06-13	2009-06-12	Novi derivati premoščen piperazinil alkanona in njihova uporaba kot p inhibitorji

Country Status (39)

Country	Link
US (2)	US8193190B2 (sl)
EP (1)	EP2297148B8 (sl)
JP (1)	JP5476373B2 (sl)
KR (1)	KR101642526B1 (sl)
CN (1)	CN102124006B (sl)
AR (1)	AR072103A1 (sl)
AT (1)	ATE540039T1 (sl)
AU (1)	AU2009259121B2 (sl)
BR (1)	BRPI0915126B8 (sl)
CA (1)	CA2727669C (sl)
CL (1)	CL2010001429A1 (sl)
CO (1)	CO6280535A2 (sl)
CR (1)	CR11832A (sl)
CY (1)	CY1112610T1 (sl)
DK (1)	DK2297148T3 (sl)
DO (2)	DOP2010000380A (sl)
EA (1)	EA019074B1 (sl)
EC (1)	ECSP10010672A (sl)
ES (1)	ES2379685T3 (sl)
FR (1)	FR2932482B1 (sl)
HK (1)	HK1158631A1 (sl)
HR (1)	HRP20120290T1 (sl)
IL (1)	IL209902A (sl)
JO (1)	JO2774B1 (sl)
MA (1)	MA32474B1 (sl)
MX (1)	MX2010013695A (sl)
MY (1)	MY150988A (sl)
NI (1)	NI201000215A (sl)
NZ (1)	NZ589840A (sl)
PE (1)	PE20110154A1 (sl)
PL (1)	PL2297148T3 (sl)
PT (1)	PT2297148E (sl)
RS (1)	RS52262B (sl)
SI (1)	SI2297148T1 (sl)
SV (1)	SV2010003755A (sl)
TW (1)	TWI432433B (sl)
UA (1)	UA101979C2 (sl)
UY (1)	UY31893A (sl)
WO (1)	WO2009150388A1 (sl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2931223B1 (fr)	2008-05-16	2010-08-20	Air Liquide	Dispositif distributeur de gaz sous pression, ensemble comprenant un tel dispositif et dispositif de commande, recipient pourvu d'un tel dispositif distributeur
FR2932481B1 (fr) *	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.
FR2953839A1 (fr)	2009-12-14	2011-06-17	Sanofi Aventis	Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75
FR2953836B1 (fr) *	2009-12-14	2012-03-16	Sanofi Aventis	Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
EP2606894A1 (en)	2011-12-20	2013-06-26	Sanofi	Novel therapeutic use of p75 receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3236243A1 (de) *	1982-09-30	1984-04-05	Merck Patent Gmbh, 6100 Darmstadt	Schwefelhaltige indolderivate
FR2744448B1 (fr) *	1996-02-02	1998-04-24	Pf Medicament	Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
US6613942B1 (en) *	1997-07-01	2003-09-02	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
WO1999001423A1 (en) *	1997-07-01	1999-01-14	Novo Nordisk A/S	Glucagon antagonists/inverse agonists
AU4198400A (en)	1999-04-06	2000-10-23	Krenitsky Pharmaceuticals Inc.	Neurotrophic thio substituted pyrimidines
UA77526C2 (en) *	2002-06-07	2006-12-15	Sanofi Aventis	Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
FR2862967B1 (fr) *	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
FR2862968B1 (fr)	2003-12-01	2006-08-04	Sanofi Synthelabo	Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique
FR2932481B1 (fr)	2008-06-13	2010-10-08	Sanofi Aventis	Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique.

2008
- 2008-06-13 FR FR0803299A patent/FR2932482B1/fr not_active Expired - Fee Related
2009
- 2009-06-04 JO JO2009204A patent/JO2774B1/en active
- 2009-06-11 TW TW098119564A patent/TWI432433B/zh active
- 2009-06-11 AR ARP090102110A patent/AR072103A1/es active IP Right Grant
- 2009-06-12 UY UY0001031893A patent/UY31893A/es not_active Application Discontinuation
- 2009-06-12 PE PE2010001120A patent/PE20110154A1/es not_active Application Discontinuation
- 2009-06-12 WO PCT/FR2009/051118 patent/WO2009150388A1/fr active Application Filing
- 2009-06-12 MX MX2010013695A patent/MX2010013695A/es active IP Right Grant
- 2009-06-12 EP EP09761939A patent/EP2297148B8/fr active Active
- 2009-06-12 PL PL09761939T patent/PL2297148T3/pl unknown
- 2009-06-12 JP JP2011513038A patent/JP5476373B2/ja active Active
- 2009-06-12 PT PT09761939T patent/PT2297148E/pt unknown
- 2009-06-12 MY MYPI20105850 patent/MY150988A/en unknown
- 2009-06-12 UA UAA201100370A patent/UA101979C2/ru unknown
- 2009-06-12 AT AT09761939T patent/ATE540039T1/de active
- 2009-06-12 AU AU2009259121A patent/AU2009259121B2/en active Active
- 2009-06-12 DK DK09761939.9T patent/DK2297148T3/da active
- 2009-06-12 BR BRPI0915126A patent/BRPI0915126B8/pt active Search and Examination
- 2009-06-12 RS RS20120137A patent/RS52262B/en unknown
- 2009-06-12 CN CN200980131366.XA patent/CN102124006B/zh active Active
- 2009-06-12 NZ NZ589840A patent/NZ589840A/xx not_active IP Right Cessation
- 2009-06-12 ES ES09761939T patent/ES2379685T3/es active Active
- 2009-06-12 EA EA201170016A patent/EA019074B1/ru not_active IP Right Cessation
- 2009-06-12 SI SI200930220T patent/SI2297148T1/sl unknown
- 2009-06-12 CA CA2727669A patent/CA2727669C/fr active Active
- 2009-06-12 KR KR1020117000792A patent/KR101642526B1/ko active IP Right Grant
2010
- 2010-12-08 CR CR11832A patent/CR11832A/es unknown
- 2010-12-08 DO DO2010000380A patent/DOP2010000380A/es unknown
- 2010-12-09 SV SV2010003755A patent/SV2010003755A/es unknown
- 2010-12-09 IL IL209902A patent/IL209902A/en active IP Right Grant
- 2010-12-10 EC EC2010010672A patent/ECSP10010672A/es unknown
- 2010-12-10 NI NI201000215A patent/NI201000215A/es unknown
- 2010-12-13 CO CO10156029A patent/CO6280535A2/es active IP Right Grant
- 2010-12-13 CL CL2010001429A patent/CL2010001429A1/es unknown
- 2010-12-13 US US12/966,413 patent/US8193190B2/en active Active
2011
- 2011-01-13 MA MA33517A patent/MA32474B1/fr unknown
- 2011-11-29 HK HK11112930.5A patent/HK1158631A1/xx not_active IP Right Cessation
2012
- 2012-04-02 HR HR20120290T patent/HRP20120290T1/hr unknown
- 2012-04-04 CY CY20121100339T patent/CY1112610T1/el unknown
- 2012-05-17 US US13/473,885 patent/US8519143B2/en active Active
2013
- 2013-06-04 DO DO2013000124A patent/DOP2013000124A/es unknown

Also Published As

Publication number	Publication date
ATE540039T1 (de)	2012-01-15
JP2011522869A (ja)	2011-08-04
SV2010003755A (es)	2011-03-15
TW201002710A (en)	2010-01-16
FR2932482B1 (fr)	2010-10-08
MY150988A (en)	2014-03-31
CL2010001429A1 (es)	2011-07-29
PL2297148T3 (pl)	2012-05-31
IL209902A0 (en)	2011-02-28
CA2727669C (fr)	2016-08-23
TWI432433B (zh)	2014-04-01
IL209902A (en)	2014-09-30
HK1158631A1 (en)	2012-07-20
CA2727669A1 (fr)	2009-12-17
KR101642526B1 (ko)	2016-07-25
CN102124006A (zh)	2011-07-13
ES2379685T3 (es)	2012-04-30
CO6280535A2 (es)	2011-05-20
UA101979C2 (ru)	2013-05-27
MX2010013695A (es)	2011-03-04
DK2297148T3 (da)	2012-05-07
BRPI0915126B8 (pt)	2021-05-25
NZ589840A (en)	2012-11-30
AU2009259121B2 (en)	2013-12-19
PE20110154A1 (es)	2011-03-14
US8519143B2 (en)	2013-08-27
US20120232280A1 (en)	2012-09-13
HRP20120290T1 (hr)	2012-04-30
US20110144116A1 (en)	2011-06-16
EA019074B1 (ru)	2013-12-30
DOP2010000380A (es)	2011-01-15
WO2009150388A1 (fr)	2009-12-17
DOP2013000124A (es)	2013-12-31
EP2297148B8 (fr)	2012-03-28
US8193190B2 (en)	2012-06-05
JP5476373B2 (ja)	2014-04-23
JO2774B1 (en)	2014-03-15
AR072103A1 (es)	2010-08-04
PT2297148E (pt)	2012-04-03
RS52262B (en)	2012-10-31
EA201170016A1 (ru)	2011-08-30
NI201000215A (es)	2011-05-04
ECSP10010672A (es)	2011-01-31
CN102124006B (zh)	2014-06-11
BRPI0915126B1 (pt)	2019-09-24
AU2009259121A1 (en)	2009-12-17
KR20110018435A (ko)	2011-02-23
EP2297148A1 (fr)	2011-03-23
UY31893A (es)	2010-01-29
MA32474B1 (fr)	2011-07-03
CY1112610T1 (el)	2016-02-10
BRPI0915126A2 (pt)	2016-02-16
EP2297148B1 (fr)	2012-01-04
FR2932482A1 (fr)	2009-12-18
CR11832A (es)	2011-02-04

Publication	Publication Date	Title
HUS1900009I1 (hu)	2019-03-28	Új vegyületek és készítmények, továbbá alkalmazási eljárásaik
HK1254895A1 (zh)	2019-08-02	苄基苯衍生物及使用方法
HK1157751A1 (en)	2012-07-06	Bridged heterocyclic compounds and methods of use
EP2480081A4 (en)	2013-03-06	Bridged heterocyclic compounds and methods for their use
HK1162352A1 (en)	2012-08-31	Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof -3-
IL213596A0 (en)	2011-07-31	Heterocyclic compounds and methods of use
IL211411A0 (en)	2011-05-31	Heteroaryls amide derivatives and their use as glucokinase activators
HK1160119A1 (en)	2012-08-10	Kinase inhibitors and methods of use
EP2252293A4 (en)	2015-06-24	KINASEHEMMER AND USE PROCESS
IL206704A0 (en)	2010-12-30	Fused heterocyclic derivatives and methods of use as c-met inhibitors
EP2262754A4 (en)	2012-03-14	MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
IL208403A0 (en)	2010-12-30	Compositions and use of epas1 inhibitors
EP2231665A4 (en)	2012-04-25	NEW COMPOSITIONS AND METHODS OF USE
ZA201007129B (en)	2011-12-28	Limk2 inhibitors,compositions comprising them,and methods of their use
EP2134352A4 (en)	2011-05-25	WNT COMPOSITIONS AND METHODS FOR THEIR USE
IL200387A0 (en)	2010-04-29	Heterocylic compounds, compositions comprising them and methods of their use
HK1158631A1 (en)	2012-07-20	Derivatives of (bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors ()-1- p75
ZA201204339B (en)	2013-08-28	Novel (heterocycle-tetrahydropyridine)(piperazinyl)-1-alcanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alcanone derivatives,and use thereof as p75 inhibitors
ZA201103179B (en)	2012-10-31	Compositions and methods of use for soluble thrombomodulin variants
EP2344454A4 (en)	2012-06-06	ANTIOXIDATION COMPOUNDS AND METHOD FOR THEIR USE